Sylvie Perron - Concepedia

Author

Sylvie Perron

Université Laval

Also Known As

S PERRON, S Perron, S. PERRON, SYLVIE PERRON, Sylvie Perron

Publications

275

Citations

H-Index

Concepts

All Affiliations

Université Laval Centre hospitalier de l'Université Laval Centre hospitalier universitaire de Québec

About

Sylvie Perron is an author at Université Laval specializing in medicine, immunotherapy, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	169
2	Public Health	1	1	27
3	Biochemistry	1	1	22
4	Biomedical Engineering	1	1	27
5	Cell Biology	1	1	22

Sylvie Perron

Publications

260

Citations

H-Index

Page 1

	Year	Citations
Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes Jean-François Gagné, André Désormeaux, Sylvie Perron, Biochimica et Biophysica Acta (BBA) - Biomembranes Human RetrovirusImmunologyAntiviral TherapyAntiviral ResponseVirology	2002	94
Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution, and pharmacokinetics Nathalie Dusserre, C Lessard, Nancy Paquette, AIDS	1995	42
Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2',3'-dideoxyinosine André Désormeaux, Pierrot Harvie, Sylvie Perron, AIDS	1994	31
Thermoreversible Gel Formulation Containing Sodium Lauryl Sulfate as a Potential Contraceptive Device Caroline Haineault, Pierrette Gourde, Sylvie Perron, Biology of Reproduction Hormonal ContraceptiveFertilityReproductive HealthSemen AnalysisBiomedical Engineering	2003	27
Ceftriaxone protects against tobramycin nephrotoxicity Denis Beauchamp, G Thériault, Louis Grenier, Antimicrobial Agents and Chemotherapy Molecular PharmacologyRenal CortexUrologyCeftriaxone ProtectsAnti-inflammatory	1994	26
Comparison of Cellular Accumulation, Tissue Distribution, and Anti-HIV Activity of Free and Liposomal 2′,3′-Dideoxycytidine Boby Makabi-Panzu, C Lessard, Sylvie Perron, AIDS Research and Human Retroviruses Anti-hiv ActivityFree DdcImmunologyAntiviral DrugImmunotherapy	1994	22
Thermoreversible Gel as a Candidate Barrier to Prevent the Transmission of HIV-1 and Herpes Simplex Virus Type 2 Jocelyne Piret, NATHALIE GAGN, Sylvie Perron, Sexually Transmitted Diseases	2001	18

Page 1